paclitaxel and fibrin
paclitaxel has been researched along with fibrin in 16 studies
Research
Studies (16)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Mayo, DJ | 1 |
| Rösner, H; Vacun, G | 1 |
| Carter, AJ; Cheng, L; Farb, A; Froehlich, J; Heller, PF; Kolodgie, FD; Scott, DS; Shroff, S; Virmani, R | 1 |
| Farb, A; Kolodgie, FD; Virmani, R | 1 |
| Balakrishnan, B; Edelman, ER; Groothuis, A; Rogers, C; Seifert, P; Tzafriri, AR | 1 |
| Acampado, E; Finn, AV; Gold, HK; Guerrero, LJ; Harnek, J; Kolodgie, FD; Skorija, K; Tefera, K; Virmani, R; Weber, DK | 1 |
| Anthony, CT; Lyons, JM; Thomson, JL; Woltering, EA | 1 |
| Baim, DS; Herbst, TJ; Huibregtse, B; Nakazawa, G; Poff, B; Schwartz, RS; Virmani, R; Wilson, GJ | 1 |
| Bayer, G; Byrne, RA; Joner, M; Lapointe, JM; Radke, PW; Steigerwald, K; Wittchow, E | 1 |
| Ahn, Y; Cho, AS; Hong, MH; Jeong, MH; Jeong, SY; Kim, JS; Kim, YS; Kwon, JS | 1 |
| Gao, H; Jiang, X; Pang, Z; Qian, Y; Wei, Y; Wu, J; Yang, Z; Yu, Y; Zhang, B; Zhao, J | 1 |
| Cheng, Y; Conditt, GB; Gongora, CA; Granada, JF; Kaluza, GL; McGregor, J; Shibuya, M; Tellez, A; Wessler, JD | 1 |
| Barry, C; Dillon, KN; Garza, JA; Granada, JF; Li, Y; Rousselle, SD; Tellez, A | 1 |
| Deng, J; Hu, Y; Jiang, T; Jiang, X; Mei, H; Pang, Z; She, X; Shen, S; Shi, W; Wang, S; Zhang, B | 1 |
| Khanna, V; Kim, H; Kirtane, AR; Koniar, B; Panyam, J; Sadhukha, T | 1 |
| Finn, AV; Harari, E; Kolodgie, FD; Mori, H; Ragheb, A; Romero, ME; Torii, S; Virmani, R; Yahagi, K; Young, B | 1 |
Reviews
2 review(s) available for paclitaxel and fibrin
| Article | Year |
|---|---|
Fibrin sheath formation and chemotherapy extravasation: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Catheterization, Central Venous; Catheters, Indwelling; Constriction, Pathologic; Cyclophosphamide; Equipment Failure; Extravasation of Diagnostic and Therapeutic Materials; Female; Fibrin; Humans; Infusions, Intravenous; Middle Aged; Paclitaxel; Plasminogen Activators; Urokinase-Type Plasminogen Activator | 1998 |
Histopathologic alterations after endovascular radiation and antiproliferative stents: similarities and differences.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brachytherapy; Coronary Restenosis; Coronary Vessels; Fibrin; Follow-Up Studies; Humans; Iliac Artery; Inflammation; Microscopy, Electron, Scanning; Paclitaxel; Platelet Aggregation; Rabbits; Radiation-Sensitizing Agents; Stainless Steel; Stents; Swine; Thrombosis | 2002 |
Other Studies
14 other study(ies) available for paclitaxel and fibrin
| Article | Year |
|---|---|
Organotypic spinal cord culture in serum-free fibrin gel: a new approach to study three-dimensional neurite outgrowth and of neurotoxicity testing: Effects of modulating the actin and tubulin dynamics and protein kinase activities.
Topics: Actins; Animals; Aprotinin; Azepines; Chick Embryo; Cytochalasin D; Densitometry; Diglycerides; Enzyme Inhibitors; Fibrin; Gels; Indoles; Neurites; Neurotoxins; Nocodazole; Organ Culture Techniques; Paclitaxel; Protein Kinases; Spinal Cord; Tetraethyl Lead; Tubulin | 1997 |
Pathological analysis of local delivery of paclitaxel via a polymer-coated stent.
Topics: Angiogenesis Inhibitors; Animals; Cell Division; Chondroitin Sulfates; Dose-Response Relationship, Drug; Drug Delivery Systems; Fibrin; Gelatin; Hemorrhage; Iliac Artery; Inflammation; Male; Paclitaxel; Polymers; Rabbits; Stents; Time Factors; Tunica Intima | 2001 |
Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents.
Topics: Animals; Arteries; Cardiovascular Agents; Computer Simulation; Equipment Design; Fibrin; Hemorheology; Humans; Models, Animal; Models, Cardiovascular; Paclitaxel; Regional Blood Flow; Stents; Swine | 2005 |
Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents.
Topics: Animals; Catheterization; Drug Therapy, Combination; Fibrin; Hyperplasia; Iliac Artery; Inflammation; Paclitaxel; Rabbits; Sirolimus; Stents; Treatment Outcome; Tunica Intima; Wound Healing | 2005 |
A novel assay to assess the effectiveness of antiangiogenic drugs in human breast cancer.
Topics: Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Biological Assay; Blood Coagulation; Breast Neoplasms; Doxorubicin; Drug Screening Assays, Antitumor; Female; Fibrin; Fluorouracil; Humans; Methotrexate; Neoplasm Invasiveness; Neovascularization, Pathologic; Paclitaxel; Thrombin; Vincristine | 2008 |
Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries.
Topics: Animals; Arteritis; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Eosinophils; Female; Fibrin; Fibrosis; Granuloma, Foreign-Body; Paclitaxel; Sirolimus; Swine; Tunica Intima | 2009 |
Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis.
Topics: Angioplasty, Balloon; Animals; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Endothelium, Vascular; Fibrin; Humans; Neointima; Paclitaxel; Swine; Wound Healing | 2011 |
Origin of restenosis after drug-eluting stent implantation in hyperglycemia is inflammatory cells and thrombus.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Body Weight; Coronary Restenosis; Diabetes Mellitus, Type 1; Disease Models, Animal; Drug-Eluting Stents; Fibrin; Humans; Hyaluronic Acid; Hyperglycemia; Inflammation; Male; Paclitaxel; Rats; Rats, Sprague-Dawley; Sirolimus; Thrombosis | 2011 |
Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Fibrin; Glioblastoma; Humans; Lactates; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Oligopeptides; Paclitaxel; Polyethylene Glycols; Random Allocation; Survival Analysis; Xenograft Model Antitumor Assays | 2014 |
Impact of Paclitaxel Dose on Tissue Pharmacokinetics and Vascular Healing: A Comparative Drug-Coated Balloon Study in the Familial Hypercholesterolemic Swine Model of Superficial Femoral In-Stent Restenosis.
Topics: Animals; Cardiovascular Agents; Coated Materials, Biocompatible; Constriction, Pathologic; Disease Models, Animal; Endovascular Procedures; Femoral Artery; Fibrin; Hyperlipoproteinemia Type II; Metals; Neointima; Paclitaxel; Peripheral Arterial Disease; Radiography; Stents; Swine; Tissue Distribution; Vascular Access Devices; Wound Healing | 2015 |
Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model.
Topics: Animals; Cardiac Catheterization; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Equipment and Supplies; Fibrin; Metals; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Stents; Swine; Tissue Distribution; Tomography, Optical Coherence; Wound Healing | 2016 |
Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude mice.
Topics: A549 Cells; Animals; Drug Delivery Systems; Fibrin; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Paclitaxel; Proteolysis; Recombinant Proteins; Tissue Plasminogen Activator; Tumor Microenvironment | 2016 |
Fibrinolytic Enzyme Cotherapy Improves Tumor Perfusion and Therapeutic Efficacy of Anticancer Nanomedicine.
Topics: Albumins; Animals; Female; Fibrin; Fibrinolysis; Fibrinolytic Agents; Humans; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanomedicine; Paclitaxel; Tissue Plasminogen Activator; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
Biologic Drug Effect and Particulate Embolization of Drug-Eluting Stents versus Drug-Coated Balloons in Healthy Swine Femoropopliteal Arteries.
Topics: Angioplasty, Balloon; Animals; Cardiovascular Agents; Coated Materials, Biocompatible; Drug-Eluting Stents; Femoral Artery; Fibrin; Models, Animal; Muscle, Skeletal; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Paclitaxel; Popliteal Artery; Proteoglycans; Sus scrofa; Time Factors; Vascular Access Devices | 2018 |